Business Description
Procaps Group SA
NAICS : 325411
SIC : 2833
ISIN : LU2376511205
Description
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.09 | |||||
| Equity-to-Asset | 0.08 | |||||
| Debt-to-Equity | 7.36 | |||||
| Debt-to-EBITDA | 2.35 | |||||
| Interest Coverage | 0.85 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.01 | |||||
| Beneish M-Score | -3.25 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.1 | |||||
| 3-Year EBITDA Growth Rate | 30.3 | |||||
| 3-Year Book Growth Rate | 84.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.93 | |||||
| 9-Day RSI | 29.8 | |||||
| 14-Day RSI | 33.11 | |||||
| 6-1 Month Momentum % | -43.48 | |||||
| 12-1 Month Momentum % | -50.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.47 | |||||
| Quick Ratio | 0.99 | |||||
| Cash Ratio | 0.13 | |||||
| Days Inventory | 195.28 | |||||
| Days Sales Outstanding | 103.43 | |||||
| Days Payable | 169.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -15.28 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.04 | |||||
| Operating Margin % | 7.88 | |||||
| Net Margin % | 12.61 | |||||
| FCF Margin % | 8.17 | |||||
| ROE % | 384.19 | |||||
| ROA % | 11.05 | |||||
| ROIC % | 6.99 | |||||
| 3-Year ROIIC % | -19.27 | |||||
| ROC (Joel Greenblatt) % | 47.08 | |||||
| ROCE % | 48.43 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 3.23 | |||||
| Forward PE Ratio | 14.36 | |||||
| PE Ratio without NRI | 56 | |||||
| PS Ratio | 0.41 | |||||
| PB Ratio | 4.81 | |||||
| Price-to-Free-Cash-Flow | 4.97 | |||||
| Price-to-Operating-Cash-Flow | 2.7 | |||||
| EV-to-EBIT | 4.28 | |||||
| EV-to-Forward-EBIT | 8.35 | |||||
| EV-to-EBITDA | 3.67 | |||||
| EV-to-Revenue | 1.1 | |||||
| EV-to-Forward-Revenue | 1.24 | |||||
| EV-to-FCF | 13.32 | |||||
| Earnings Yield (Greenblatt) % | 23.36 | |||||
| FCF Yield % | 17.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Procaps Group SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 386.925 | ||
| EPS (TTM) (€) | 0.483 | ||
| Beta | 0 | ||
| Volatility % | 87.01 | ||
| 14-Day RSI | 33.11 | ||
| 14-Day ATR (€) | 0.050058 | ||
| 20-Day SMA (€) | 1.481 | ||
| 12-1 Month Momentum % | -50.94 | ||
| 52-Week Range (€) | 1.3 - 3.7 | ||
| Shares Outstanding (Mil) | 112.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Procaps Group SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Procaps Group SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Procaps Group SA Frequently Asked Questions
What is Procaps Group SA(FRA:9X1)'s stock price today?
The current price of FRA:9X1 is €1.30. The 52 week high of FRA:9X1 is €3.70 and 52 week low is €1.30.
When is next earnings date of Procaps Group SA(FRA:9X1)?
The next earnings date of Procaps Group SA(FRA:9X1) is 2024-10-01 Est..
Does Procaps Group SA(FRA:9X1) pay dividends? If so, how much?
Procaps Group SA(FRA:9X1) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers